North America Infectious Disease Molecular Diagnostics Market Size & Outlook
North America infectious disease molecular diagnostics market, 2018-2030 (US$M)
Related Markets
North America infectious disease molecular diagnostics market highlights
- The North America infectious disease molecular diagnostics market generated a revenue of USD 6,522.2 million in 2024.
- The market is expected to grow at a CAGR of 3.5% from 2025 to 2030.
- In terms of segment, reagents product was the largest revenue generating product in 2024.
- Others Product is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 6,522.2 million |
| Market revenue in 2030 | USD 8,026.9 million |
| Growth rate | 3.5% (CAGR from 2025 to 2030) |
| Largest segment | Reagents product |
| Fastest growing segment | Others Product |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments Product, Reagents Product, Others Product |
| Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
Other key industry trends
- In terms of revenue, North America region accounted for 41.0% of the global infectious disease molecular diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Latin America is the fastest growing regional market and is projected to reach USD 1,034.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Disease Molecular Diagnostics Market Scope
Infectious Disease Molecular Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America infectious disease molecular diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.67% in 2024. Horizon Databook has segmented the North America infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
North American market held the highest market share owing to increasing adoption of molecular diagnostics, due to their high accuracy, sensitivity, and specificity. Increasing need for molecular testing to detect infectious diseases, for early detection of infections in patients with underlying medical conditions, such as diabetes, and rising number of drugresistant infections are major market drivers.
There has been an increase in the number of strategic partnerships between major pharmaceuticals and molecular diagnostics manufacturing companies, to develop infectious disease molecular diagnostics, which can be attributed to the COVID-19 pandemic.
The recent novel coronavirus pandemic is expected to positively impact market growth. By September 2020, the U.S. had used over 150 million molecular diagnostic tests for detection of COVID-19 virus infection. However, shortage of the supply of materials, such as reagents, required to perform diagnostic tests is expected to impede market growth.
Reasons to subscribe to North America infectious disease molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America infectious disease molecular diagnostics market databook
-
Our clientele includes a mix of infectious disease molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America infectious disease molecular diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into North America infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America infectious disease molecular diagnostics market size, by country, 2018-2030 (US$M)
North America Infectious Disease Molecular Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
